Evaluation of latent-transforming growth factor beta-binding protein, dopamine and serotonin in patients with chronic epilepsy according to disease type and body mass index

Abstract

The study aimed to evaluate some biochemical, immunological, physiological and neurotransmitter variables in chronic epilepsy patients.  The study comprised 60 patients with epilepsy and a control group of 30 healthy persons, aged between 15 and 60 years. The investigation involved quantifying the amounts of dopamine, serotonin, latent-transforming growth factor beta-binding protein 1 (LTBP1), alkaline phosphatase (ALP), aspartate aminotransferase (AST), and alanine aminotransferase (ALT). The findings of the present investigation indicated the following: A notable reduction (p≤0.01) in the levels of latent transforming growth factor binding proteins (LTBP1) relative to the control group. A notable elevation (p≤0.01) in the levels of dopamine, alkaline phosphatase (ALP), aspartate aminotransferase (AST), and alanine aminotransferase (ALT) was observed in comparison to the control values. A substantial elevation (p≤0.05) in serotonin levels was observed relative to the control data. This study indicated a reduction in the levels of LTBP1. The concentration of dopamine, serotonin, AST, ALT, and ALP is elevated in patients with persistent epilepsy compared to healthy individuals.